ALNS

Latest SEC Filings & News for ALNS

1 most recent filing and news item mentioning ALNS. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/ALNS/news?limit=20"

Pull ALNS filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Alumis files corporate deck outlining precision TYK2 inhibitors

Alumis Inc. submitted an exhibit detailing its precision engineered TYK2 inhibitors and pipeline strategy. The presentation provides an overview of clinical plans regarding envudeucitinib and future therapies for immune-mediated diseases.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.